BackAVEO Pharmaceuticals Overview

AVEO Pharmaceuticals Current Cash

Track AVEO Pharmaceuticals's current cash ($77M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$77.40M
17.68% YoYΔ $-16.62M vs prior year quarter

Peer trimmed avg / median

Loading

AVEO Pharmaceuticals Current Cash History

Loading

AVEO Pharmaceuticals vs. peers: Current Cash Comparison

Loading

AVEO Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AVEO Pharmaceuticals (AVEO) FAQ

The latest current cash for AVEO is $77M as of September 2022. That compares with $94M in the prior-year period — down 17.7% year over year. Investors often review this figure alongside AVEO Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, AVEO's current cash moved from $94M to $77M — a 17.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AVEO Pharmaceuticals's operating scale or balance-sheet position.

A current cash figure of $77M for AVEO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AVEO's current cash ($77M), review year-over-year change from $94M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack AVEO Pharmaceuticals's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.